The efficiency of chemotherapy with immunomodulators for patients with destructive lung tuberculosis.
Immunomodulators are to be prescribed to tuberculous patients in accordance with clinical and immunologic indices for 2 months. Taking into account that levamisol in dose 100 mg/24 hours is well tolerated by the patients and is as efficient as in the dose 150 mg/24 hours it is recommended to use this agent in dose 100 mg/24 hours three times a week. As it became evident from the clinical-roentgenologic, bacteriologic and immunologic data diuciphon is better tolerated by the patients and more efficient than levamisol.
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D000995:Antitubercular Agents / Q000627:therapeutic use*; D004338:Drug Combinations / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006801:Humans; D007111:Immunity, Cellular / Q000187:drug effects; D007978:Levamisole / Q000627:therapeutic use; D013450:Sulfones / Q000627:therapeutic use; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy* / Q000276:immunology; D014498:Uracil / Q000031:analogs & derivatives / Q000627:therapeutic use
D000276:Adjuvants, Immunologic; D000995:Antitubercular Agents; D004338:Drug Combinations; D013450:Sulfones; D007978:Levamisole; C023367:diucifon; D014498:Uracil